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Abstract
Machine learning algorithms designed to characterize, monitor, and intervene on
human health (ML4H) are expected to perform safely and reliably when operating
at scale, potentially outside strict human supervision. This requirement warrants a
stricter attention to issues of reproducibility than other fields of machine learning.
In this work, we conduct a systematic evaluation of over 100 recently published
ML4H research papers along several dimensions related to reproducibility. We
find that the field of ML4H compares poorly to more established machine learning
fields, particularly concerning data and code accessibility. Finally, drawing from
success in other fields of science, we propose recommendations to data providers,
academic publishers, and the ML4H research community in order to promote
reproducible research moving forward.
1 Introduction
Science requires reproducibility, but many sub-fields of science have recently experienced a repro-
ducibility crisis, eroding trust in processes and results and potentially influencing the rising rates
of scientific retractions [1, 5, 45]. Reproducibility is also critical for machine learning research,
whose goal is to develop algorithms to reliably solve complex tasks at scale, with limited or no
human supervision. Failure of a machine learning system to consistently replicate an intended
behavior in a context different from which that behavior was defined may result in dramatic, even
fatal, consequences [28]. Ranking prominently among machine learning applications that may put
human lives at stake are those related to Machine Learning for Health (ML4H). In a field where
applications are meant to directly affect human health, findings should undergo heavy scrutiny along
the validation pipeline from research findings to applications deployed in the wild. For example, in
2018, 12 AI tools using ML4H algorithms to inform medical diagnosis and treatment were cleared
by Food and Drug Administration (FDA) and will be marketed to and potentially used by millions of
Americans [32]. Verifying the reproducibility of the claims put forward by the device manufacturer
should thus be a main priority of regulatory bodies [37], extending the need for reproducible ML4H
results beyond the machine learning research community.
Unfortunately, several factors relating to the availability, quality, and consistency of clinical or
biomedical data make reproducibility especially challenging in ML4H applications. In this work,
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we make several contributions. First, we present a taxonomy of reproducibility tailored to ML4H
applications, and designed to capture reproducibility goals more broadly. Second, we use this taxon-
omy to define several metrics geared towards quantifying the particular challenges in reproducibility
faced within ML4H, and conduct a comprehensive review of the published literature to support our
claims and compare ML4H to machine learning more generally. Finally, we build on this analysis by
exploring promising areas of further research for reproducibility in ML4H.
2 A Reproducibility Taxonomy
The common understanding of reproducibility in machine learning can be summed up as follows: A
machine learning study is reproducible if readers can fully replicate the exact results reported in the
paper. We will call this concept technical replicability, as it is centrally concerned with whether or not
one can replicate the precise, technical results of a paper under identical conditions. Though intuitive,
we argue technical replicability is actually only a small part of the goal of “reproducibility” more
generally. This discrepancy has been noted historically in various ways [6, 15, 21, 39] and is made
apparent by the use of the term in the natural and social sciences, where attempted reproductions will
often occur at different labs, using different equipment/staff, etc. We argue that in order for a study to
be fully reproducible, it must meet three tiers of replicability:
Technical Replicability Can results be replicated under technically identical conditions?
Statistical Replicability Can results be replicated under statistically identical conditions?
Conceptual Replicability Can results be replicated under conceptually identical conditions?
Technical replicability refers to the ability of a result to be fully technically replicated, yielding the
precise results reported in the paper. For example, this entails aspects of reproducibility related
to code and dataset release. Statistical replicability refers to the ability of a result to hold under
re-sampled conditions that yield different technical configurations, but should not statistically affect
the claimed result (e.g., a different set of random seeds, or train/test splits). Note this is related,
but not identical, to the notion of internal validity [3] commonly used in social science research.
Similarly, conceptual replicability is heavily related to external validity [38], as it describes the notion
of how well the desired results reproduces under conditions that mach the conceptual description
of the purported effect. Note that this is task-definition dependent; claiming a task has a greater
conceptual horizon of generalizability makes it harder to satisfy this reproducibility requirement.
All three of these replicability criteria are central for full reproducibility: without technical repli-
cability, one’s result cannot be demonstrated. Without statistical replicability, one’s result will not
reproduce under increased sampling and the presence of real-world variance. And lastly, without
conceptual replicability, one’s result does not depend on the desired properties of the data, but instead
depends on potentially unobserved aspects of the data generation mechanism that, critically, will not
reproduce when deployed in practice.
Under each of these lenses, ML4H differs from general machine learning domains in critical ways
and presents unique challenges.
3 Core Reproducibility Challenges in ML4H
In this section, we illustrate both through qualitative arguments and a quantitative literature review
that ML4H lags behind other subfields of machine learning on various reproducibility metrics. Our
literature review procedure entailed manually extracting and annotating over 300 papers from various
venues, spanning ML4H, Natural Language Processing (NLP), Computer Vision (CV), and general
machine learning (general ML).2 The full procedure used for this statistical review is detailed in the
Appendix (Section 5), and final quantitative results on several key metrics can be seen in Figure 1,
though they are also detailed in the text where appropriate. The full set of results is available at
https://github.com/evidation-health/ICLR2019.
2NLP and CV were chosen to represent broad fields with a significant applied focus, much like ML4H.
General ML was chosen to have an unbiased comparison to the field more broadly.
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Figure 1: Fraction of papers satisfying certain conditions by ML field. See the Appendix (Section 5)
for detailed descriptions of the underlying data collection procedure. Note that ML4H consistently
lags other subfields of machine learning on all measures of reproducibility save inclusion of proper
statistical variance.
3.1 Technical Replicability
ML4H faces several key challenges with regards to technical replicability. Firstly, health data is
privacy sensitive, making it difficult to release openly without either incurring risks of re-identification,
or severely diminishing utility by applying aggressive de-identification techniques [7]. As a result,
few public datasets are available, and those that are available are used extremely frequently, leading
to a risk of dataset-specific over-fitting. To this point, approximately only 51% of the ML4H papers
we examined used public datasets, as compared to over 90% of both CV and NLP papers, and
approximately 77% of general ML papers.
ML4H scores even more poorly when it comes to code release, preprocessing specification, and cohort
description; only approximately 13% of the papers we analyzed released their code publicly, compared
to approximately 37% in CV and 50% in NLP. A previous study that reviewed the prevalence of
code release in AI reported that only 6% of papers released code [15], which is lower than all of our
estimates. This discrepancy may be due to sampling papers from different conferences and different
time periods (2013-2016 vs. 2018 for the current study). Specific prior works have also already
examined the prevalence of code release and dataset cohort sub-selection within ML4H, finding that
even when restricting focus to public datasets, studies often do not release code or include sufficiently
informative text to enable a full technical reproduction [17, 24]. Note that code release is itself
not necessarily sufficient for full technical replicability; even when code is released, it may not run
correctly, it may exclude critical details, or it may fail to generate the results reported in the paper.
3.2 Statistical Replicability
To assess the state of statistical replicability in ML4H, we quantified how often papers describe
the variance around their results (e.g., by listing both the mean and the standard deviation of a
performance metric over several random splits). Interestingly, while ML4H’s rate of this is still
relatively low (approximately 38%), it is higher than that of CV, NLP, or the general domain (17%,
33%, and 32%, respectively).
Though this is an encouraging sign, we feel there is still significant room for improvement. Even
in other fields of machine learning, with arguably less complex data types, repeated studies have
shown that published models fail to statistically reproduce when appropriate statistical procedures are
implemented and fair hyperparameter search/preprocessing methods are used: in [42], researchers
find that published models evaluated using the public ImageNet test set show consistent performance
drops when trained/tested on other random splits within ImageNet, and in [31, 30], researchers find
that published performance deltas between various model architectures for language models and
generative adversarial networks, respectively, fail to persist under more robust hyperparameter search
and statistical comparison techniques. In [18], researchers examine practices in deep reinforcement
learning which can limit or enhance studies’ reproducibility. Due to our inability to technically
replicate many ML4H works given dataset and code release issues, we cannot assess the extent of
these issues to the same degree in ML4H. However, it seems doubtless that similar problems affect
our field, perhaps to an even greater degree given that our datasets are frequently relatively small,
high dimensional, sparse/irregularly sampled, and suffer from high rates of noise.
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Figure 2: Summary of recommendations for different stakeholders.
3.3 Conceptual Replicability
The critical issue in ML4H preventing conceptual replicability is the lack of multi-institution datasets
in healthcare and the lack of usage of those that do exist. Whereas approximately 83% of CV
studies and approximately 66% of NLP studies used multiple datasets to establish their results, only
approximately 19% of ML4H studies did. Using only a single dataset is potentially dangerous, as it
is known that developing ML4H models that generalize over changing care practices or data formats
is challenging. In [13], researchers demonstrate the dangers of training a model on raw data from
one institution and transferring to another (using a simulated institutional divide within the MIMIC
dataset), and in [35], researchers establish that without using manually engineered representations,
ML4H models exhibit significant degradation in performance over time as care patterns evolve. These
results are not surprising; health data is rife with hidden confounders, differs significantly between
data collection and deployment environments, drifts over time, and further differs in structure and
concept between different healthcare institutions [4].
4 Opportunities for Improvement
In this section, we present several practical suggestions for enhancing reproducibiltiy for ML4H from
the perspective of three main ML4H stakeholders: the ML4H research community, data providers,
and related journals and conferences. Figure 2 summarizes these suggestions.
4.1 Create Shared Research Resources
Data providers such as hospitals, clinical research centers, and government agencies produce vast
amounts of valuable data. Unfortunately, as suggested by our literature review, few datasets are
available for a wide range of researchers to explore. We call for more instances of large data trusts
where medical institutions can anonymously pool data for researchers to use and create algorithms.
Several prominent examples already exist for the field to draw on in creating such repositories,
including MIMIC [25], the U.K and Japan Biobanks [33, 44], eICU [40], the Temple University
Hospital EEG Corpus [16], and Physionet [12]. This recommendation is especially compelling as
corporate entities increasingly invest in the ML4H space, particularly with regards to data [41, 50].
Anchoring our research progress to large scale datasets in non-public or non-academic hands poses a
dangerous precedent, especially in light of recent patent filings [2, 14].
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4.2 Integrate Multi-Institute Datasets
Multi-institute datasets enable studies to assess their ability to translate to new contexts, a critically
understudied facet of ML4H research. Recent strides have been taken in this domain with the
release of the eICU dataset [40], one of ML4H’s first large scale, multi-institution EHR datasets,
and researchers are already analyzing how to form generalizable models using this resource [22].
Lastly, Observational Health Data Sciences and Informatics (OHDSI) [20] provides a mechanism
to run observational health studies across multiple institutions and countries. We encourage more
collaborative efforts in this area from data providers to improve conceptual replicability.
4.3 Prospectively Collect Data
Data collected as a by-product of care, then later released for research purposes (e.g., MIMIC [23]),
presents serious privacy risks and contains many confounding variables. The landscape of these
privacy risks and the nature of the confounding variables change (though they do not necessarily
lessen) if data is instead prospectively collected directly from new, consented participants. These
types of data collection regimes are logistically challenging, but are possible. The NIH’s All of Us
Research Program [34], Evidation’s DiSCover Project [9], and Google’s Project Baseline [47] are
examples of these approaches.
4.4 Adopt Rigorous Statistical Methods
ML4H researchers should be more rigorous in the development, refinement, and dissemination of
statistical best practices (e.g., the proper procedures for model comparisons, etc.). Holding ourselves
to high standards of statistical rigor, potentially including periodic statistical audits of our own
statistical replicability, will help ensure we mitigate the problems other fields have found with “over-
fitting via publication,” e.g. [42]. Several commonly-used challenges already exist in ML4H with
fixed train/test sets (e.g., [11, 43]) which could be used for these kind of post-hoc replication studies.
4.5 Develop New Privacy-Preserving Analysis Techniques
Technological solutions can also be employed to help mitigate privacy concerns. ML4H researchers
can explore noised, fully- or partially- simulated, or encrypted datasets. In cases where data cannot
be released, techniques to train distributed models without sharing data have been proposed [46].
Synthetic data can be an excellent tool to help enable researchers to still meaningfully release their
code with full end-to-end realizations of their pipeline, as is done in, e.g., [51]. Technology for
producing synthetic patient-level data also already exists [48].
4.6 Propose Pre-Registration Alternatives
In the biomedical sciences, “observational studies,” under which definition nearly all ML4H research
falls, undergo intense scrutiny to ensure they are not susceptible to statistical artifacts—in particular,
increasingly these studies are required to be pre-registered,3 a move promoted by scientists and major
journals alike [26, 29, 49]. Such prospective checks make unintentional statistical fraud more difficult,
but are utterly absent in ML4H. A verbatim application of the pre-registration practice in use in the
epidemiology community is likely an impractical solution due to the intrinsic exploratory nature of
model development, but other techniques, such as systematic re-release of new data and/or rotation of
official train/test splits have been found to help reduce the presence of statistical errors in other fields.
ML4H researchers and academic publishers should engage in serious conversation on what the best
vehicle for these checks and balances are.
4.7 Establish Reporting Requirements and Require Code Release
If conferences and journals required greater rates of data/code release, or the use of additional
data/code availability statements at publication, this would instill a significant pressure on the field
3 Meaning they are required to report their goal and planned preprocessing/modeling scheme before they
run any experiments in order to avoid intentional or unintentional statistical fraud. This idea is not without its
detractors [27, 8].
5
to address some of the foundational barriers to reproducibility. Conferences and journals have the
additional ability to insist on high standards for the reporting of statistical variance around results,
hyperparameter search procedures, and evaluation mechanisms, each of which would help ensure
that we maintain high standards of technical and statistical replicability.
4.8 Develop Data Standards and Reporting Standards
Collaborative efforts in developing data standards and reporting standards is another avenue for
improving reproducibility. Healthcare analytics organizations have developed data standards like
the OMOP standard [36] or the FHIR standard [19], but they are not commonly adopted in ML4H
research. Increased use of standards would make it easier to technically and conceptually replicate
ML4H studies. Similarly, when ML4H datasets are created, we need greater descriptions of their
contents, potential confounders and biases, missing data prevalence and distribution, and how they
were created. Increasing the use of “specs” or “datasheets” describing datasets would help allay these
concerns—efforts in the broader machine learning community are also approaching this goal [10]
and we should vigorously adopt these practices in ML4H.
5 Conclusion
In this work, we have framed the question of reproducibility in ML4H around three foundational
lenses: technical, statistical, and conceptual replicability. In each of these areas, we argue both
qualitatively and quantitatively, through a manual, extensive review of the literature, that ML4H
performs worse than other machine learning fields in several reproducibility metrics we have identified.
While keeping in mind the intrinsic challenges of data acquisition and use that plague the field, we
highlight several areas of opportunities for the future, focused around improving access to data,
expanding our trajectory of statistical rigor, and increasing the use of multi-source data to better
enable conceptual reproducibility.
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Appendix: Statistical Review Procedures
Selection Criteria Papers were selected at random, to ensure an unbiased sample, from various
venues associated with different domains (though papers were tagged with their content-driven
domain at annotation time). A full list of venues, along with the number of papers analyzed from
each, is presented in Table 1. All publicly-accessible papers within the ML4H venues were used,
rather than a random sub-sample, given the venues’ limited sizes. Except for papers from MLHC2017
and ICCV, all papers were published in 2018. We conducted a similar review for 2018 papers only
and the results were consistent.
Domain Conference # Papers Examined
ML4H
MLHC 2017 25∗
MLHC 2018 31∗
ML4H Poster-Accepts 2018 57∗
KDD Health Day 2018 21∗
NLP
ACL 30
EMNLP 30
NAACL 30
CV
CVPR 21
ICCV 21
ECCV 21
ML
NeurIPS 14
ICML 14
ICLR 14
KDD 14
AAAI 14
Table 1: Sources and coverage statistics for our manual literature review. ∗ indicates all publicly-
accessible papers published were used.
Annotation Procedure Each paper was reviewed by only one annotator, and in total 8 annotators
were used, 3 of which are authors on this work. Annotation tasks were designed to be quick, to enable
us to profile a large number of papers at a coarse level rather than a small number of papers in depth.
As such, annotators were only asked the following questions:
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1. Was code released?
2. What datasets were used?
3. Are these datasets publicly available (modulo data use agreements)?
4. Do the authors report any notion of variance around their results or assess their comparisons
to baselines in a statistically robust fashion (e.g., via hypothesis testing)?
Potential Biases This selection and annotation procedure allowed us to analyze a large number of
papers, but has several possible biases. In particular, our annotation questions were all of these were
designed to be determinable via quick, scanning techniques and as a result this task took on average
between 45 seconds and 3 minutes per paper. In such a limited time, some losses are unavoidable.
We recognize several sources of possible bias worth mentioning.
Firstly, some papers may, for example, release datasets or code products external to the paper and
not mention it in the actual text. We will omit these associated products. If such effects induce a
notable bias in our results, however, we must question why as a field we are comfortable releasing
our code/data without any mention in the associated paper.
Secondly, not all papers intended to be analyzed were publicly accessible. Similarly, the versions of
papers we analyzed could have been different from the version presented at the actual conference
venue, or there could exist updated versions of papers we analyzed in different repositories. Our
analysis technique will miss these effects.
Thirdly, some papers naturally fit into multiple categories (e.g., a work focused on medical named
entity recognition would be both a ML4H work and an NLP work). In the interest of ensuring our
comparison classes were as pure as possible, we omitted all clearly multi-domain works, but allowed
works that centered primarily in a single domain to remain.
Lastly, different fields present different kinds of works, and not all works fit into our framework.
Largely theoretical works, for example, often have no real datasets or public experiments. Similarly,
presenting variance is a different question for works focused principally around computational
efficiency rather than predictive accuracy. We handled these issues by attempting to answer these
questions as best we could, and flagging any papers that overtly did not fit our scheme and excluding
them from our analyses.
Data Release We release all data as a result of these analyses publicly, accessible at
https://github.com/evidation-health/ICLR2019.
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